Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardium

Echocardiography

Volumn 24, Issue 7, 2007, Pages 739-744

  Sawada, Stephen G ^a   Safadi, Anas ^a   Gaitonde, Rajdeep S ^a   Tung, Nisha ^b   Mahenthiran, Jothiharan ^a   Gill, William ^a   Ghumman, Waqas ^a   Gradus Pizlo, Irmina ^a   Kamalesh, Masoor ^a   Fineberg, Naomi ^a   Feigenbaum, Harvey ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Coronary artery disease; Dobutamine; Stress echocardiography

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; FEMALE; HEART EJECTION FRACTION; HEART MOVEMENT; HEART RATE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTION ANALYSIS SYSTEM; MULTIVARIATE ANALYSIS; MYOCARDIAL DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; SYSTOLIC DYSFUNCTION;

CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34447617839     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00471.x     Document Type: Article

References (20)

1. Dies F, Krell MJ, Whitlow P, et al : Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986 74 (suppl II II 38.
2. Feldman AM, Bristow MR, Parmley WW, et al : Effects of vesnarinone on morbidity and mortality in patients with heart failure: Vesnarinone Study Group. N Engl J Med 1993 329 : 149 155.
3. Oliva F, Latini R, Politi A, et al : Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE Multicenter Trial. Am Heart J 1999 138 : 247 253.
4. Felker GM, O'Connor CM : Inotropic therapy for heart failure: An evidence-based approach. Am Heart J 2001 : 142 393 401.
5. Stevenson LW : Clinical use of inotropic therapy for heart failure: Looking backward or forward? Part I: Inotropic infusions during hospitalization. Circulation 2003 108 : 367 372.
6. Schulz R, Rose J, Martin C, et al : Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993 88 : 684 695.
7. Afridi I, Kleiman NS, Raizner AE, et al : Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995 91 : 663 670.
8. Cornel JH, Bax JJ, Elhendy A, et al : Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998 31 : 1002 1010.
9. Sawada S, Elsner G, Segar DS, et al : Evaluation of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol 1997 29 : 55 61.
10. Segar DS, Brown SE, Sawada SG, et al : Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992 19 : 1197 1202.
11. Lelonek M, Machraoui A : Effect of coronary stenosis diameter on variability of on-line quantitative and qualitative arteriography. Heart Vessels 1997. Suppl 12 221 223.
12. Gould KL, Lipscomb K : Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974 34 : 48 55.
13. Kaul S, Senior S, Dittrich H, et al : Detection of coronary artery disease with myocardial contrast echocardiography: Comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 1997 96 : 785 792.
14. Severi A, Underwood R, Mohiaddin RH, et al : Dobutamine stress: Effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol 1995 26 : 1187 1195.
15. Chaudry FA, Bangalore S, Yao S-S, et al : Comparison of stress-induced myocardial ischemia in patients with and without coronary arterial collaterals. Am J Cardiol 2004 94 : 1232 1236.
16. van Liebergen RAM, Piek JJ, Koch KT, et al : Quantification of collateral flow in humans: A comparison of angiographic, electrocardiographic and hemodynamic variables. J Am Coll Cardiol 1999 33 : 670 677.
17. Kupper W, Waller D, Hanrath P, et al : Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease. Eur Heart J 1982 3 : 29 34.
18. Eitzman D, Ziad Al-Aouar Z, Kanter HL, et al : Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992 20 : 559 565.
19. Beanlands RSB, Hendry PJ, Masters RG, et al : Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998 II : 51 56.
20. White CW, Wright CB, Doty DB, et al : Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis N Engl J Med 1984 310 : 819 24.